Literature DB >> 29741577

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C Marth, F Landoni, S Mahner, M McCormack, A Gonzalez-Martin, N Colombo.   

Abstract

Entities:  

Year:  2018        PMID： 29741577     DOI： 10.1093/annonc/mdy160

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  28 in total

1.  SEOM clinical guidelines for cervical cancer (2019).

Authors:  A de Juan; A Redondo; M J Rubio; Y García; J Cueva; L Gaba; A Yubero; J Alarcón; C Maximiano; A Oaknin
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

Review 2.  Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.

Authors:  Shinya Matsuzaki; Maximilian Klar; Mikio Mikami; Muneaki Shimada; Brendan H Grubbs; Keiichi Fujiwara; Lynda D Roman; Koji Matsuo
Journal:  Curr Oncol Rep       Date:  2020-02-12       Impact factor: 5.075

Review 3.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

Review 4.  Increasing global accessibility to high-level treatments for cervical cancers.

Authors:  C Chargari; M Arbyn; A Leary; N R Abu-Rustum; P Basu; F Bray; S Chopra; R Nout; K Tanderup; A N Viswanathan; C Zacharopoulou; J C Soria; E Deutsch; S Gouy; P Morice
Journal:  Gynecol Oncol       Date:  2021-10-27       Impact factor: 5.304

5.  A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells.

Authors:  Xiaolong Li; Yingwen Huang; Pengfei Wang; Wei Song; Qingmei Yao; Qiping Hu; Sufang Zhou
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

6.  MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.

Authors:  Shuzhen Tian; Lili Lou; Mengyuan Tian; Guangping Lu; Jianghua Tian; Xi Chen
Journal:  J Exp Clin Cancer Res       Date:  2020-07-25

7.  Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes.

Authors:  Weikang Guo; Hui Yu; Lu Zhang; Xiuwei Chen; Yunduo Liu; Yaoxian Wang; Yunyan Zhang
Journal:  Cancer Cell Int       Date:  2019-09-09       Impact factor: 5.722

8.  Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.

Authors:  Suzy Scholl; Marina Popovic; Anne de la Rochefordiere; Elodie Girard; Sylvain Dureau; Aljosa Mandic; Katarina Koprivsek; Nina Samet; Marius Craina; Madalin Margan; Sanne Samuels; Henry Zijlmans; Gemma Kenter; Peter Hillemanns; Sorin Dema; Alis Dema; Goran Malenkovic; Branislav Djuran; Anne Floquet; Delphine Garbay; Frédéric Guyon; Pierre Emmanuel Colombo; Michel Fabbro; Christine Kerr; Charlotte Ngo; Fabrice Lecuru; Eleonor Rivin Del Campo; Charles Coutant; Frédéric Marchal; Nathalie Mesgouez-Nebout; Virginie Fourchotte; Jean Guillaume Feron; Philippe Morice; Eric Deutsch; Pauline Wimberger; Jean-Marc Classe; Noreen Gleeson; Heiko von der Leyen; Mathieu Minsat; Coraline Dubot; Pierre Gestraud; Attila Kereszt; Istvan Nagy; Balazs Balint; Els Berns; Ekaterina Jordanova; Nicolas de Saint-Jorre; Alexia Savignoni; Nicolas Servant; Philippe Hupe; Leanne de Koning; Pierre Fumoleau; Roman Rouzier; Maud Kamal
Journal:  EBioMedicine       Date:  2019-04-02       Impact factor: 8.143

9.  miR‑218 functions as a tumor suppressor gene in cervical cancer.

Authors:  Zhen Liu; Lin Mao; Linlin Wang; Hong Zhang; Xiaoxia Hu
Journal:  Mol Med Rep       Date:  2019-11-11       Impact factor: 2.952

10.  Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer.

Authors:  Hodjatollah Shahbazian; Mohammad Javad Tahmasebi Birgani; Ali Bagheri; Shole Arvandi; Sasan Razmjoo; Pari Ghadamgahi; Roksana Bakhali; Maryam Feli
Journal:  J Contemp Brachytherapy       Date:  2020-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.